Takeda Pharmaceutical Company Limited Effect Of Exchange Rate Changes On Cash And Cash Equivalents
Takeda Pharmaceutical Company Limited (TKPHF) reported Effect Of Exchange Rate Changes On Cash And Cash Equivalents of -JPY 11.38 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Cash Flow
ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents · last filed 2025-06-25
| Period end | Effect Of Exchange Rate Changes On Cash And Cash Equivalents 12 month | Effect Of Exchange Rate Changes On Cash And Cash Equivalents 12 month as first filed |
|---|---|---|
| 2025-03-31 | -11.38B JPY 20-F · filed 2025-06-25 | |
| 2024-03-31 | 26.20B JPY 20-F · filed 2025-06-25 | |
| 2023-03-31 | 22.93B JPY 20-F · filed 2025-06-25 | |
| 2022-03-31 | 28.76B JPY 20-F · filed 2024-06-26 | |
| 2021-03-31 | 12.50B JPY 20-F · filed 2023-06-28 | |
| 2020-03-31 | -21.77B JPY 20-F · filed 2022-06-29 | 21.77B JPY 20-F · filed 2020-06-24 |
| 2019-03-31 | -31.27B JPY 20-F · filed 2021-06-29 | 31.27B JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 4.57B JPY 20-F · filed 2020-06-24 | |
| 2017-03-31 | 5.74B JPY 20-F · filed 2019-06-27 |